JP2004307484A - Antiseptic bactericide, and cosmetic, pharmaceutical and foodstuff blended with the same - Google Patents

Abstract

<P>PROBLEM TO BE SOLVED: To provide an antiseptic bactericide in which a 5-10C 1,2-alkane diol and a chelating agent are contained for enhancing the bactericidal activity intrinsic to 1,2-alkane diol, and to provide cosmetics, pharmaceuticals and foodstuffs blended with the bactericide. <P>SOLUTION: This antiseptic bactericide contains the 5-10C 1,2-alkane diol and chelating agent. The cosmetics, pharmaceuticals and foodstuffs are blended with the bactericide. <P>COPYRIGHT: (C)2005,JPO&NCIPI

Description

  The present invention relates to an antiseptic disinfectant and cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant. An object of the present invention is to contain a 1,2-alkanediol having 5 to 10 carbon atoms and a chelating agent to thereby enhance the antibacterial activity inherent to 1,2-alkanediol, An object of the present invention is to provide cosmetics, medicines, and foods containing an antiseptic and a disinfectant.

BACKGROUND ART In cosmetics (including quasi-drugs), pharmaceuticals, foods, and the like, parabens, benzoic acids, salicylic acids, and the like are used as preservatives and disinfectants. However, the above-mentioned antiseptic disinfectant has a drawback that its use concentration range is limited due to high skin irritation and low safety. For example, the use limit concentration of paraben or benzoate is 1%, and the use limit concentration of benzoic acid or salicylic acid is 0.2%.
In addition, since the above-mentioned antiseptic disinfectant is easily affected by pH, the stability of the antiseptic disinfecting effect is poor, and further, in combination with other components such as a surfactant, the antiseptic antibacterial activity is significantly reduced. There was also a problem that there were cases.

  In recent years, the number of people who have an allergic reaction to the above-mentioned antiseptic disinfectant tends to increase, and the direction for safety has been further increased, and the above-mentioned antiseptic disinfectant has not been added at all, or its combination Demand for cosmetics, pharmaceuticals, foods, and the like with reduced amounts is increasing.

  As a technique for reducing or eliminating an antiseptic disinfectant, an antiseptic disinfectant comprising 1,2-alkanediol (see Patent Document 1) and a moisturizing bacteriostatic agent for detergency or non-detergency cosmetic comprising 1,2-octanediol (See Patent Document 2). However, when a 1,2-alkanediol such as 1,2-octanediol is used alone as an antiseptic, a high blending amount may be required in order to obtain sufficient effectiveness. Since 2,2-alkanediol has a peculiar raw material odor, there is a demand for a technique capable of exhibiting a sufficient antiseptic and sterilizing effect even at a low content.

  In addition, as a technique relating to an antiseptic disinfectant using 1,2-alkanediol, an external composition (see Patent Document 3) in which 1,2-pentanediol and 2-phenoxyethanol are combined, and 1,2-alkanediol and An antiseptic disinfectant comprising paraben (see Patent Document 4) is disclosed. However, these are intended to improve the effect of the preservative by using a preservative in combination with a 1,2-alkanediol such as 1,2-pentanediol, and to completely eliminate the preservative itself. It was not intended to enhance the antibacterial activity of 1,2-alkanediol.

JP-A-11-325991 JP 2001-48720 A JP-A-10-53510 JP-A-11-310506

  In view of such circumstances, the present inventors have conducted intensive research and have found that by using both a 1,2-alkanediol and a chelating agent as an antiseptic and bactericide, the antibacterial activity inherent in 1,2-alkanediol is enhanced. And completed the present invention.

That is, the invention according to claim 1 relates to an antiseptic disinfectant containing a 1,2-alkanediol having 5 to 10 carbon atoms and a chelating agent.
The invention according to claim 2 relates to the preservative disinfectant according to claim 1, wherein the 1,2-alkanediol is 1,2-hexanediol and / or 1,2-octanediol.
The invention according to claim 3 relates to the antiseptic disinfectant according to claim 1, wherein the 1,2-alkanediol is 1,2-octanediol.
The invention according to claim 4 is characterized in that the chelating agent is at least one selected from the group consisting of edetic acid, polyphosphoric acid, pyrophosphoric acid, gluconic acid, and salts thereof. 3. The antiseptic disinfectant according to any one of (3).
The invention according to claim 5 is characterized in that the chelating agent is at least one selected from the group consisting of edetic acid, polyphosphoric acid, gluconic acid, and salts thereof. And a preservative disinfectant according to the present invention.
The invention according to claim 6 relates to a cosmetic, pharmaceutical or food product containing the antiseptic disinfectant according to any one of claims 1 to 5.

  Since the antiseptic disinfectant according to the present invention contains a 1,2-alkanediol and a chelating agent, the antibacterial activity inherent to the 1,2-alkanediol is enhanced. Therefore, it is not necessary to mix a conventional antiseptic disinfectant, and high safety can be obtained.

When 1,2-hexanediol or 1,2-octanediol is used as the 1,2-alkanediol, an antiseptic having a higher antibacterial activity can be obtained.
If one or more selected from the group consisting of edetic acid, polyphosphoric acid, gluconic acid, and salts thereof is used as a chelating agent, a preservative bactericide having higher antibacterial activity can be obtained.

  The cosmetics, pharmaceuticals and foods containing the antiseptic disinfectant according to the present invention need not contain conventional antiseptic disinfectants such as salicylic acid, benzoic acid and paraben, and the antiseptic disinfectant according to the present invention has excellent antibacterial activity. Therefore, the antiseptic disinfectant itself can be used in a low blending amount, and is extremely safe.

  Hereinafter, the antiseptic disinfectant according to the present invention will be described in detail. The preservative disinfectant according to the present invention contains a 1,2-alkanediol and a chelating agent.

  The first component of the antiseptic disinfectant according to the present invention is a 1,2-alkanediol having 5 to 10 carbon atoms represented by the following formula (1), and specifically, 1,2-pentanediol. , 1,2-hexanediol, 1,2-heptanediol, 1,2-octanediol, 1,2-nonanediol, and 1,2-decanediol.

（但し、式中、ｎは２〜７の整数を示す。）

(In the formula, n represents an integer of 2 to 7.)

In the present invention, one of the aforementioned 1,2-alkanediols having 5 to 10 carbon atoms can be used alone, or two or more can be used in combination.
1,2-Alkanediol itself has an excellent antibacterial activity, and exhibits an effect of increasing the antibacterial activity of the antiseptic disinfectant according to the present invention. In particular, in the present invention, among 1,2-alkanediols having 5 to 10 carbon atoms, it is preferable to use 1,2-hexanediol and 1,2-octanediol, and it is more preferable to use 1,2-octanediol. preferable.

The second component of the preservative disinfectant according to the present invention is a chelating agent.
Chelating agents are not particularly limited, for example, edetic acid, nitrilotriacetic acid, hydroxyethylethylenediaminetriacetic acid, diethylenetriaminepentaacetic acid, triethylenetetraminehexaacetic acid, cyclohexanediaminepentaacetic acid, glycine, serine, alanine, lysine, cystine, tyrosine, Methionine, ascorbic acid, citric acid, malic acid, tartaric acid, lactic acid, oxalic acid, malonic acid, maleic acid, erythorbic acid, succinic acid, fumaric acid, pyruvic acid, salicylic acid, gluconic acid, polyacrylic acid, polymaleic acid, pyrophosphoric acid , Tripolyphosphoric acid, polyphosphoric acid, orthophosphoric acid, and salts thereof.
Examples of the salt of the chelating agent include a sodium salt, a potassium salt, a calcium salt and the like.
One chelating agent may be used alone, or two or more chelating agents may be mixed and used.

  By using a chelating agent together with a 1,2-alkanediol having 5 to 10 carbon atoms, the antibacterial action of the 1,2-alkanediol having 5 to 10 carbon atoms can be synergistically enhanced. In particular, in the present invention, among the above-mentioned chelating agents, one or more of edetic acid, polyphosphoric acid, pyrophosphoric acid, gluconic acid, and salts thereof are preferable because a higher antibacterial action can be obtained. One or more of edetic acid, polyphosphoric acid, gluconic acid and salts thereof are more preferably used.

  In the antiseptic disinfectant according to the present invention, the content of the first component, a 1,2-alkanediol having 5 to 10 carbon atoms and the chelating agent, which is the second component, is not particularly limited. It is blended so as to be 100 to 100: 1, preferably 1:10 to 10: 1. When 1,2-alkanediol is added more than 100 times the amount of the chelating agent, and when the chelating agent is added more than 100 times the amount of the 1,2-alkanediol, the antibacterial activity is enhanced. It is not preferable because the effect cannot be expected.

  Since the antiseptic disinfectant according to the present invention contains a 1,2-alkanediol as a first component and a chelating agent as a second component, as shown in a test example described below, Due to the synergistic effect of the component and the second component, an excellent antiseptic and bactericidal action is exhibited. Therefore, it is not necessary to mix or use a conventionally used antiseptic disinfectant such as paraben, benzoic acid, and salicylic acid, and it is possible to obtain extremely high safety.

The antiseptic disinfectant according to the present invention described above can be used by blending it in cosmetics, pharmaceuticals, foods, and the like.
Specifically, facial cleansers, lotions, emulsions, creams, foundations, mascara, nail enamel, lipsticks, and other skin cosmetics, shampoos, hair treatments, hair restoration / hair restoration, hair creams, hair lotions, hair foams, Hair cosmetics such as permanent waving agents, medicated cosmetics (quasi-drugs) with specific purposes such as spots and freckles, acne treatments, gargles, troches and other pharmaceuticals, as well as chewing gum, candy, It can be suitably used for foods such as beverages.

When preparing cosmetics, pharmaceuticals or foods using the antiseptic disinfectant according to the present invention, components normally used in cosmetics, pharmaceuticals or foods can be appropriately mixed as long as the effects of the present invention are not impaired. . For example, in the case of cosmetics and pharmaceuticals (including quasi-drugs), oils and fats, waxes, higher fatty acids, lower alcohols, higher alcohols, sterols, fatty acid esters, humectants, surfactants, polymer compounds, inorganic pigments, pigments Fragrances, antioxidants, ultraviolet absorbers, vitamins, astringents, whitening agents, plant and animal extracts, purified water, and the like.
In the case of food, animal and vegetable oils, polysaccharides, sweeteners, coloring agents, gum bases and the like can be exemplified.

  When preparing cosmetics, pharmaceuticals or foods, the amount of the antiseptic disinfectant according to the present invention is not particularly limited, but is 0.01 to 20% by weight, preferably 0.05 to 5% by weight in the composition. Even if the content exceeds 20% by weight, no further effect can be expected. On the other hand, if the amount is less than 0.01% by weight, the antibacterial effect is inferior, so that it is not preferable.

[Example 1]
(Test bacteria)
As test bacteria, Escherichia coli IFO3972 (Escherichia coli), Pseudomonas aeruginosa IFO13275 (Pseudomonas aeruginosa) and Candida albicans IFO1594 (oral candidiasis) were used.

(Preparation of bacterial solution for inoculation)
In the case of Escherichia coli and Pseudomonas aeruginosa, the inoculum was cultured at 35 ° C. on an agar medium, and then transplanted to a bouillon medium and cultured at 35 ° C. Those resulting broth was diluted to approximately 10 ⁸ cells / mL in broth was inoculated for bacterial solution.
Also, in the case of oral candidiasis bacteria was inoculated for bacterial solution diluted to about ¹⁰⁷ cells / mL were cultured in the same manner at 30 ° C..

(Preparation of dilution series of test substance)
5,4,3,2.5,2.25,2,1.75,1.5,1.25,1w / v% 1,2-octane using 20 w / w% ethyl cellosolve as a diluting solvent A diol solution was prepared.
Further, with respect to disodium edetate and an equal mixture of 1,2-octanediol and disodium edetate, a dilution series was prepared by diluting a 5% w / v% solution twice.

(Measurement of minimum growth inhibitory concentration (MIC))
9 mL of each agar medium was placed in a Petri dish with 1 mL of the dilution series containing the test substance, and the bacterial solution for inoculation was streaked to a length of about 1 cm for each. Culture was performed at 35 ° C. for Escherichia coli and Pseudomonas aeruginosa, and the presence or absence of growth of the bacteria two days later was determined. Moreover, about the oral candidiasis bacteria, it culture | cultivated at 25 degreeC and the presence or absence of growth of the bacteria after 3 days was determined. At this time, the minimum concentration at which no growth was observed was determined as MIC. Table 1 shows the results.

  The antimicrobial activity can be evaluated by MIC. When the concentration of the test substance is low, there is no effect on the microorganism, but as the concentration increases, the growth is inhibited. To this extent, growth suppression is advanced depending on the concentration, and growth is eventually stopped. The concentration at this time is expressed as MIC. Therefore, when the concentration becomes higher than the MIC, the microorganisms will die.

(Binary minimum inhibitory concentration)
Each MIC of the obtained 1,2-octanediol, disodium edetate, and an equal weight mixture of 1,2-octanediol and disodium edetate was used as the blending amount of 1,2-octanediol and disodium edetate. , And a binary minimum growth inhibitory concentration diagram was obtained.
The action and effect when two kinds of substances having antibacterial properties are blended can be determined from the binary minimum growth inhibitory concentration. Specifically, when two kinds of substances having antibacterial properties are blended, the resulting action is roughly classified into a synergistic action, an additive action, and an antagonistic action. The synergistic action is an action in which the two drugs act synergistically to further enhance the intrinsic antibacterial activity. The additive action is an action obtained by combining the antibacterial activities of the respective drugs. Antagonistic action is the action when one drug counteracts the antimicrobial activity of another drug. The method based on the binary minimum growth inhibition concentration diagram is, for example, a method of measuring the MIC of the substance A and the substance B at different ratios as shown in FIG. According to this, a point obtained by plotting the MIC of only the substance A (point A) and the MIC of the substance B only (point B) is connected, and the MIC when both substances are used together is inside the line (point C) is a synergistic effect in which the antibacterial activity is enhanced by the combined use, if it is on the line (point D), it is an additive effect, and if it is outside the line (point E), it is one or both. It can be determined that the antimicrobial activity is an antagonistic action that counteracts the antibacterial activity and decreases the antibacterial activity.
FIG. 2 shows a binary minimum inhibitory concentration diagram for disodium edetate.

[Example 2]
The same operation as in Example 1 was carried out using sodium polyphosphate as a chelating agent and Pseudomonas aeruginosa and oral candidiasis as test bacteria, and the MIC in Table 2 and the binary minimum growth inhibitory concentration diagram in FIG. 3 were obtained. .

[Example 3]
Using sodium gluconate as a chelating agent and Staphylococcus aureus IFO13276 (Staphylococcus aureus) as a test bacterium, the same operation as in the case of Escherichia coli of Example 1 was performed, and the MIC of Table 3 and the binary minimum growth of FIG. An inhibitory concentration diagram was determined.

(Evaluation of antibacterial effect)
From the results of FIGS. 2 to 4, the combination of 1,2-octanediol and a chelating agent such as disodium edetate, sodium polyphosphate, and sodium gluconate shows that the antibacterial activity inherent in 1,2-octanediol is It can be seen that they are synergistically enhanced.

Hereinafter, examples of blending cosmetics, pharmaceuticals, and foods containing the antiseptic disinfectant according to the present invention will be described.
<Prescription example 1: moisturizing cream>
Decaglyceryl monolaurate 1.0
POE (15) glyceryl monostearate 1.0
Hydrogenated soybean phospholipid 1.0
Stearic acid 4.0
Cetanol 2.0
Behenyl alcohol 2.0
Paraffin 3.0
Squalane 12.0
Jojoba oil 4.0
Methyl polysiloxane 0.2
1,3-butylene glycol 3.0
L-arginine 0.1
Xanthan gum 0.001
1,2-octanediol 0.25
Disodium edetate 0.10
Purified water qs
100.0% by weight in total

<Prescription example 2: hydrophilic ointment>
Ascorbic acid 0.5
Polyoxyethylene cetyl ether 2.0
Hydrogenated soybean phospholipid 1.0
Stearic acid 4.0
Glycerin monostearate 10.0
Liquid paraffin 10.0
Vaseline 4.0
Cetanol 5.0
Propylene glycol 5.0
1,2-hexanediol 0.5
Sodium polyphosphate 0.2
Purified water qs
100.0% by weight in total

<Formulation Example 3: Beverage>
Glucose liquid sugar 33.0
Grapefruit juice 64.0
1,2-pentanediol 0.5
Sodium polyphosphate 0.01
Fragrance 0.5
Acidulant qs
100.0% by weight in total

The preservative disinfectant according to the present invention synergistically enhances the preservative disinfecting activity inherent in 1,2-alkanediol by using a 1,2-alkanediol having 5 to 10 carbon atoms and a chelating agent in combination. Therefore, it is useful as an antiseptic disinfectant for cosmetics, pharmaceuticals, foods, and the like.
The cosmetic, pharmaceutical or food according to the present invention contains a 1,2-alkanediol having 5 to 10 carbon atoms and a chelating agent as preservatives, so that the amount of the conventional preservatives is reduced. It can be used in a blended amount or a substantially non-blended amount, and is useful as cosmetics, pharmaceuticals or foods having high safety.

It is a figure which shows an example of the method of judging the action effect produced when two types of substances having antibacterial properties are blended from the binary minimum growth inhibitory concentration. FIG. 3 is a binary minimum growth inhibitory concentration diagram for Example 1. FIG. 7 is a binary minimum growth inhibitory concentration diagram for Example 2. FIG. 8 is a binary minimum growth inhibitory concentration diagram for Example 3.

Claims (6)

An antiseptic disinfectant comprising a 1,2-alkanediol having 5 to 10 carbon atoms and a chelating agent. 2. The antiseptic according to claim 1, wherein the 1,2-alkanediol is 1,2-hexanediol and / or 1,2-octanediol. The antiseptic according to claim 1, wherein the 1,2-alkanediol is 1,2-octanediol. The preservative according to any one of claims 1 to 3, wherein the chelating agent is at least one selected from the group consisting of edetic acid, polyphosphoric acid, pyrophosphoric acid, gluconic acid, and salts thereof. Fungicide. The preservative disinfectant according to any one of claims 1 to 3, wherein the chelating agent is at least one selected from the group consisting of edetic acid, polyphosphoric acid, gluconic acid, and salts thereof. A cosmetic, pharmaceutical, or food product containing the antiseptic disinfectant according to any one of claims 1 to 5.

Images